Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
AYTU
#3661
AYTU BioPharma, Inc. Common Stock
2.5
7
+3.21%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+3.21%
Monatliche Änderung
-3.02%
6 month change
+7.98%
Jahresänderung
+102.36%
Vorheriger Schlusskurs
2.4
9
Open
2.5
7
Bid
Ask
Low
2.5
7
High
2.5
7
Volumen
1
Märkte
Aktien
Gesundheitswesen
AYTU
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
TTM
Dividends per share
—
—
—
—
—
Dividend yield %
—
—
—
—
—
Payout ratio %
—
—
—
—
—
Nachrichten
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript
Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates
Aytu BioPharma 2분기 매출 감소, 주가 하락
Earnings call transcript: Aytu BioPharma Q2 2026 sees revenue dip, stock falls
New Strong Sell Stocks for February 2nd
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day - Slideshow (NASDAQ:AYTU) 2026-01-20
Aytu launches EXXUA, first selective 5-HT1A agonist for depression
Aytu BioPharma, 우울증 치료제 EXXUA 출시 후 주가 상승
Aytu BioPharma stock rises after commercial launch of depression drug EXXUA
Aytu BioPharma, 우울증 치료제 EXXUA 미국 시장 출시
Aytu BioPharma launches depression drug EXXUA in U.S. market